BBNX
Beta Bionics, Inc.
-1.15 (-5.18%)21.03USD1.5M成交股數946M市值–本益比(近四季)8.0股價營收比+37.8%營收年增(近四季)2026-10-27下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 14 · 1.9M · 6 |
| 其中 10b5-1 計畫賣出 | 9 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 2.5M |
| 近 180 天 淨額 | −2.5M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 | 09-15 | Hopman Mark | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 775 | 15.52 | 12K | 86.4K | SEC |
| 2026-09-09 | 09-10 | Hopman Mark | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 36.9K | 18.46 | 681K | 87.2K | SEC |
| 2026-09-03 | 09-04 | Saint Sean | President & CEO | S 公開市場賣出(10b5-1) | 5.6K | 20.08 | 113K | 398K | SEC |
| 2026-09-02 | 09-03 | Mensinger Mike | Chief Product Officer | S 公開市場賣出 | 4.4K | 19.11 | 84K | 180K | SEC |
| 2026-09-02 | 09-03 | Russell Steven Jon | Chief Medical Officer | S 公開市場賣出 | 4.2K | 19.11 | 81K | 170K | SEC |
| 2026-09-02 | 09-03 | Saint Sean | President & CEO | S 公開市場賣出 | 16.9K | 19.11 | 322K | 404K | SEC |
| 2026-09-02 | 09-03 | Feider Stephen | Chief Financial Officer | S 公開市場賣出 | 6.7K | 19.11 | 128K | 159K | SEC |
| 2026-09-02 | 09-03 | Hopman Mark | Chief Commercial Officer | S 公開市場賣出 | 5.3K | 19.11 | 102K | 124K | SEC |
| 2026-06-29 | 07-02 | Feider Stephen | Chief Financial Officer | M 選擇權執行 | 4.9K | 5.10 | 25K | 171K | SEC |
| 2026-06-29 | 07-02 | Feider Stephen | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.9K | 17.03 | 83K | 166K | SEC |
| 2026-06-29 | 06-30 | Feider Stephen | Chief Financial Officer | M 選擇權執行 | 4.9K | 5.10 | 25K | 171K | SEC |
| 2026-06-29 | 06-30 | Feider Stephen | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.9K | 17.03 | 83K | 166K | SEC |
| 2026-06-26 | 07-02 | Feider Stephen | Chief Financial Officer | M 選擇權執行 | 5.1K | 5.10 | 26K | 171K | SEC |
| 2026-06-26 | 07-02 | Feider Stephen | Chief Financial Officer | S 公開市場賣出(10b5-1) | 5.1K | 17.05 | 87K | 166K | SEC |
| 2026-06-26 | 06-30 | Feider Stephen | Chief Financial Officer | M 選擇權執行 | 5.0K | 5.10 | 25K | 171K | SEC |
| 2026-06-26 | 06-30 | Feider Stephen | Chief Financial Officer | S 公開市場賣出(10b5-1) | 5.1K | 17.05 | 87K | 166K | SEC |
| 2026-06-24 | 06-25 | Jones Christy | Director | S 公開市場賣出(10b5-1) | 1.4K | 15.00 | 21K | 26.0K | SEC |
| 2026-06-24 | 06-25 | Hopman Mark | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 1.3K | 15.01 | 19K | 129K | SEC |
| 2026-06-04 | 06-05 | Jones Christy | Director | S 公開市場賣出(10b5-1) | 2.8K | 14.00 | 39K | 27.4K | SEC |
| 2026-06-04 | 06-05 | Hopman Mark | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 275 | 12.31 | 3K | 131K | SEC |
| 2026-06-02 | 06-03 | Feider Stephen | Chief Financial Officer | S 公開市場賣出 | 6.7K | 12.61 | 84K | 166K | SEC |
| 2026-06-02 | 06-03 | Hopman Mark | Chief Commercial Officer | S 公開市場賣出 | 5.3K | 12.61 | 67K | 131K | SEC |
| 2026-06-02 | 06-03 | Mensinger Mike | Chief Product Officer | S 公開市場賣出 | 4.4K | 12.61 | 55K | 184K | SEC |
| 2026-06-02 | 06-03 | Saint Sean | President & CEO | S 公開市場賣出 | 16.9K | 12.61 | 213K | 421K | SEC |
| 2026-06-02 | 06-03 | Russell Steven Jon | Chief Medical Officer | S 公開市場賣出 | 4.2K | 12.61 | 53K | 174K | SEC |
| 2026-05-22 | 05-26 | Lezack Adam | Director | S 公開市場賣出(10b5-1) | 998 | 11.21 | 11K | 27.4K | SEC |
| 2026-05-21 | 05-26 | Palasis Maria | Director | A 獲配股票 | 17.0K | – | – | 29.4K | SEC |
| 2026-05-21 | 05-26 | Lezack Adam | Director | A 獲配股票 | 17.0K | – | – | 28.4K | SEC |
| 2026-05-21 | 05-26 | MICHEL GERARD J | Director | A 獲配股票 | 17.0K | – | – | 33.5K | SEC |
| 2026-05-21 | 05-26 | Jones Christy | Director | S 公開市場賣出(10b5-1) | 2.0K | 9.95 | 20K | 13.2K | SEC |
| 2026-05-21 | 05-26 | Jones Christy | Director | A 獲配股票 | 17.0K | – | – | 30.2K | SEC |
| 2026-05-21 | 05-26 | CARNEY SEAN | Director | A 獲配股票 | 17.0K | – | – | 32.2K | SEC |
| 2026-05-21 | 05-26 | Dearen Danny L. | Director | A 獲配股票 | 17.0K | – | – | 32.2K | SEC |
| 2026-05-21 | 05-26 | Lezack Adam | Director | S 公開市場賣出(10b5-1) | 1.0K | 9.95 | 10K | 11.4K | SEC |
| 2026-03-04 | 03-05 | Hopman Mark | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 353 | 11.57 | 4K | 139K | SEC |
| 2026-03-02 | 03-03 | Mensinger Mike | Chief Product Officer | S 公開市場賣出 | 1.1K | 12.36 | 13K | 189K | SEC |
| 2026-03-02 | 03-03 | Feider Stephen | Chief Financial Officer | S 公開市場賣出 | 1.4K | 12.36 | 18K | 173K | SEC |
| 2026-03-02 | 03-03 | Russell Steven Jon | Chief Medical Officer | S 公開市場賣出 | 1.0K | 12.36 | 13K | 179K | SEC |
| 2026-03-02 | 03-03 | Saint Sean | President & CEO | S 公開市場賣出 | 3.4K | 12.36 | 42K | 438K | SEC |
| 2026-03-02 | 03-03 | Hopman Mark | Chief Commercial Officer | S 公開市場賣出 | 834 | 12.36 | 10K | 139K | SEC |
| 2026-02-27 | 03-03 | Saint Sean | President & CEO | A 獲配股票 | 343K | – | – | 441K | SEC |
| 2026-02-27 | 03-03 | Hopman Mark | Chief Commercial Officer | A 獲配股票 | 109K | – | – | 140K | SEC |
| 2026-02-27 | 03-03 | Mensinger Mike | Chief Product Officer | A 獲配股票 | 109K | – | – | 190K | SEC |
| 2026-02-27 | 03-03 | Feider Stephen | Chief Financial Officer | A 獲配股票 | 132K | – | – | 174K | SEC |
| 2026-02-27 | 03-03 | Russell Steven Jon | Chief Medical Officer | A 獲配股票 | 109K | – | – | 180K | SEC |
| 2026-01-13 | 01-14 | MICHEL GERARD J | Director | A 獲配股票 | 4.0K | – | – | 16.5K | SEC |
| 2026-01-13 | 01-14 | Jones Christy | Director | A 獲配股票 | 4.0K | – | – | 15.2K | SEC |
| 2026-01-13 | 01-14 | Palasis Maria | Director | A 獲配股票 | 4.0K | – | – | 12.4K | SEC |
| 2026-01-13 | 01-14 | Lezack Adam | Director | A 獲配股票 | 4.0K | – | – | 12.4K | SEC |
| 2026-01-13 | 01-14 | CARNEY SEAN | Director | A 獲配股票 | 4.0K | – | – | 15.2K | SEC |
| 2026-01-13 | 01-14 | Dearen Danny L. | Director | A 獲配股票 | 4.0K | – | – | 15.2K | SEC |
| 2026-01-06 | 01-07 | Mensinger Mike | Chief Product Officer | S 公開市場賣出(10b5-1) | 2.2K | 30.10 | 66K | 80.8K | SEC |
| 2026-01-02 | 01-05 | Mensinger Mike | Chief Product Officer | S 公開市場賣出(10b5-1) | 7.2K | 29.56 | 213K | 83.6K | SEC |
| 2026-01-02 | 01-05 | Feider Stephen | Chief Financial Officer | S 公開市場賣出(10b5-1) | 20.0K | 29.53 | 591K | 42.6K | SEC |
| 2026-01-02 | 01-05 | Feider Stephen | Chief Financial Officer | M 選擇權執行 | 20.0K | 5.10 | 102K | 62.6K | SEC |
| 2026-01-02 | 01-05 | Mensinger Mike | Chief Product Officer | S 公開市場賣出(10b5-1) | 600 | 30.20 | 18K | 83.0K | SEC |
| 2025-12-04 | 03-16 | Hopman Mark | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 2.1K | 30.66 | 63K | 136K | SEC |
| 2025-12-02 | 03-16 | Hopman Mark | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 856 | 29.34 | 25K | 138K | SEC |
| 2025-12-02 | 03-16 | Russell Steven Jon | Chief Medical Officer | S 公開市場賣出 | 1.0K | 29.34 | 30K | 178K | SEC |
| 2025-12-02 | 12-04 | Saint Sean | President & CEO | S 公開市場賣出 | 3.3K | 29.34 | 96K | 97.9K | SEC |
| 2025-12-02 | 12-04 | Mensinger Mike | Chief Product Officer | S 公開市場賣出 | 1.1K | 29.34 | 31K | 90.8K | SEC |
| 2025-12-02 | 12-04 | Feider Stephen | Chief Financial Officer | S 公開市場賣出 | 1.4K | 29.34 | 42K | 42.6K | SEC |
| 2025-12-01 | 12-02 | Lezack Adam | Director | S 公開市場賣出(10b5-1) | 906 | 29.35 | 27K | 8.9K | SEC |
| 2025-12-01 | 12-02 | Palasis Maria | Director | S 公開市場賣出(10b5-1) | 906 | 29.33 | 27K | 8.9K | SEC |
| 2025-12-01 | 12-02 | Palasis Maria | Director | S 公開市場賣出(10b5-1) | 500 | 29.96 | 15K | 8.4K | SEC |
| 2025-12-01 | 12-02 | Lezack Adam | Director | S 公開市場賣出(10b5-1) | 500 | 29.91 | 15K | 8.4K | SEC |
| 2025-10-31 | 11-05 | Palasis Maria | Director | S 公開市場賣出(10b5-1) | 119 | 27.45 | 3K | 9.8K | SEC |
| 2025-10-31 | 11-05 | Palasis Maria | Director | S 公開市場賣出(10b5-1) | 1.3K | 26.86 | 35K | 10.0K | SEC |
| 2025-10-31 | 11-05 | Lezack Adam | Director | S 公開市場賣出(10b5-1) | 1.4K | 26.85 | 37K | 9.9K | SEC |
| 2025-10-31 | 11-05 | Lezack Adam | Director | S 公開市場賣出(10b5-1) | 38 | 27.70 | 1K | 9.8K | SEC |
| 2025-10-03 | 10-07 | Feider Stephen | Chief Financial Officer | S 公開市場賣出(10b5-1) | 3.8K | 21.52 | 82K | 45.2K | SEC |
| 2025-10-03 | 10-07 | Feider Stephen | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.2K | 22.28 | 26K | 44.0K | SEC |
| 2025-10-03 | 10-07 | Feider Stephen | Chief Financial Officer | M 選擇權執行 | 5.0K | 5.10 | 25K | 49.0K | SEC |
| 2025-10-01 | 10-03 | Feider Stephen | Chief Financial Officer | S 公開市場賣出(10b5-1) | 14.9K | 20.76 | 310K | 44.1K | SEC |
| 2025-10-01 | 10-03 | Feider Stephen | Chief Financial Officer | S 公開市場賣出(10b5-1) | 100 | 21.08 | 2K | 44.0K | SEC |
| 2025-10-01 | 10-03 | Feider Stephen | Chief Financial Officer | M 選擇權執行 | 15.0K | 5.10 | 77K | 59.1K | SEC |
| 2025-09-08 | 09-09 | Feider Stephen | Chief Financial Officer | M 選擇權執行 | 9.9K | 5.10 | 50K | 53.9K | SEC |
| 2025-09-08 | 09-09 | Feider Stephen | Chief Financial Officer | S 公開市場賣出(10b5-1) | 9.9K | 21.13 | 209K | 44.0K | SEC |
| 2025-09-05 | 09-08 | Feider Stephen | Chief Financial Officer | M 選擇權執行 | 100 | 5.10 | 510.00 | 44.1K | SEC |
| 2025-09-05 | 09-08 | Hopman Mark | Chief Commercial Officer | M 選擇權執行 | 11.4K | 5.10 | 58K | 42.6K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | 6.3M | 98.1M | 新進 | 新進 |
| Soleus Capital Management, L.P. | 4.4M | 68.8M | 新進 | 新進 |
| MORGAN STANLEY | 4.3M | 66.9M | 新進 | 新進 |
| Sands Capital Alternatives, LLC | 3.7M | 58.1M | 新進 | 新進 |
| BlackRock, Inc. | 3.3M | 52.3M | 新進 | 新進 |
| Point72(柯恩) Point72 Asset Management, L.P. | 2.3M | 35.3M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | 27.9M | 新進 | 新進 |
| Vestal Point Capital, LP | 1.6M | 25.1M | 新進 | 新進 |
| RTW INVESTMENTS, LP | 1.5M | 23.5M | 新進 | 新進 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.3M | 20.7M | 新進 | 新進 |
| Omega Fund Management, LLC | 1.3M | 20.6M | 新進 | 新進 |
| Eversept Partners, LP | 1.2M | 19.6M | 新進 | 新進 |
| Divisadero Street Capital Management, LP | 1.1M | 17.5M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | 16.8M | 新進 | 新進 |
| STATE STREET CORP | 970K | 15.2M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 956K | 15.0M | 新進 | 新進 |
| Balyasny Asset Management L.P. | 856K | 13.4M | 新進 | 新進 |
| PERCEPTIVE ADVISORS LLC | 833K | 13.1M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 703K | 12.0M | 新進 | 新進 |
| Bruce & Co., Inc. | 666K | 10.4M | 新進 | 新進 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 595K | 9.3M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 547K | 8.6M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 537K | 8.4M | 新進 | 新進 |
| Trexquant Investment LP | 494K | 7.7M | 新進 | 新進 |
| Tri Locum Partners LP | 493K | 7.7M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 134 +4 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 134 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 48.0M · 100.0% |
| 合計季末市值 | 752M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 9.4M |
|---|---|
| 與上期比 | +25.4% |
| 佔流通股數 | 20.90% |
| 日均成交量 | 1.0M |
| 回補天數 | 9.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 9.4M | +25.4% | 20.90% | 1.0M | 9.0 |
| 2026-08-14 | 7.5M | -1.4% | 16.66% | 1.4M | 5.5 |
| 2026-07-31 | 7.6M | +15.1% | 16.90% | 1.3M | 6.0 |
| 2026-07-15 | 6.6M | -3.1% | 14.69% | 949K | 7.0 |
| 2026-06-30 | 6.8M | +45.9% | 15.16% | 1.2M | 5.9 |
| 2026-06-15 | 4.7M | -10.1% | 10.39% | 1.0M | 4.5 |
| 2026-05-29 | 5.2M | -8.6% | 11.56% | 721K | 7.2 |
| 2026-05-15 | 5.7M | -8.2% | 12.64% | 625K | 9.1 |
| 2026-04-30 | 6.2M | -13.2% | 13.77% | 1.2M | 5.2 |
| 2026-04-15 | 7.1M | -6.1% | 15.86% | 1.1M | 6.6 |
| 2026-03-31 | 7.6M | +8.5% | 16.89% | 1.2M | 6.6 |
| 2026-03-13 | 7.0M | +24.5% | 15.57% | 1.1M | 6.3 |
| 2026-02-27 | 5.6M | -2.2% | 12.51% | 1.3M | 4.3 |
| 2026-02-13 | 5.8M | +5.0% | 12.79% | 1.1M | 5.4 |
| 2026-01-30 | 5.5M | -1.3% | 12.18% | 1.0M | 5.3 |
| 2026-01-15 | 5.6M | -24.0% | 12.34% | 2.0M | 2.8 |
| 2025-12-31 | 7.3M | +81.6% | 16.23% | 1.1M | 6.8 |
| 2025-12-15 | 4.0M | +4.1% | 8.94% | 938K | 4.3 |
| 2025-11-28 | 3.9M | +8.1% | 8.58% | 427K | 9.0 |
| 2025-11-14 | 3.6M | -0.9% | 7.94% | 576K | 6.2 |
| 2025-10-31 | 3.6M | -13.6% | 8.01% | 889K | 4.1 |
| 2025-10-15 | 4.2M | -34.7% | 9.27% | 475K | 8.8 |
| 2025-09-30 | 6.4M | +64.4% | 14.19% | 1.4M | 4.7 |
| 2025-09-15 | 3.9M | +24.8% | 8.63% | 806K | 4.8 |
| 2025-08-29 | 3.1M | +16.6% | 6.91% | 598K | 5.2 |
| 2025-08-15 | 2.7M | -36.3% | 5.93% | 599K | 4.5 |